Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

The neuroendocrine prostate cancer treatment space will experience significant changes during the forecast period of 2025–2034, owing to the launch o ...

A mum who enrolled in a college course after her son’s type 1 diabetes diagnosis is now building a successful career in science after 20 years ...

Valued at $199.1 billion by market cap, Merck & Co., Inc. (MRK) is a leading American biopharmaceutical company based in ...

Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of ...

Sorbitan Tristearate is projected to dominate the product type segment, commanding a 28% market share by 2025. Its critical ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

July 7 – With a 90-day negotiating period on country-specific US tariffs is set to expire on July 9, Trump enacts a multitude ...

Employees of the technology transfer centre ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...